AmyW.ZhouMD

PubMed

• 7 citations
  Hepcidin is elevated in primary and secondary myelofibrosis and remains elevated in patients treated with ruxolitinib.
  Amy Zhou, Tim Kong, Jared S Fowles, Chun-Ling Jung, Maggie J Allen, Daniel A C Fisher, Mary Fulbright, Elizabeta Nemeth, Tomas Ganz, Stephen T Oh> ;British Journal of Haematology. 2022 May 1
• 29 citations
  Roxadustat for the treatment of anemia in patients with lower-risk myelodysplastic syndrome: Open-label, dose-selection, lead-in stage of a phase 3 study.
  David H. Henry, John A. Glaspy, Rosemary Harrup, Moshe Mittelman, Amy Zhou, Hetty E. Carraway, Charles Bradley, Gopal Saha, Katharina Modelska, Pamela Bartels, Robert ...> ;American Journal of Hematology. 2021 Nov 9
• 50 citations
  Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms.
  Daniel Arthur Corpuz Fisher, Jared S. Fowles, Amy Zhou, Stephen T. Oh> ;Frontiers in Immunology. 2021 Jun 1
• 77 citations
  Cytokine production in myelofibrosis exhibits differential responsiveness to JAK-STAT, MAP kinase, and NFκB signaling.
  Daniel A.C. Fisher, Cathrine A. Miner, Elizabeth K. Engle, Hengrui Hu, Taylor B. Collins, Amy Zhou, Maggie J. Allen, Olga Malkova, Stephen T. Oh> ;Leukemia. 2019 Feb 4
• 40 citations
  Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience.
  Nikolaos A. Trikalinos, Amy Zhou, Maria B. Doyle, Kathryn J. Fowler, Ashley Morton, Neeta Vachharajani, Manik Amin, Jesse Keller, William C. Chapman, Elizabeth M. Brun...> ;Journal of the National Comprehensive Cancer Network. 2018 Oct 1
• 3 citations
  An Analysis of the Inclusion of Medications Considered Potentially Inappropriate in Older Adults in Chemotherapy Templates for Hematologic Malignancies: One Recommenda...
  Amy Zhou, Holly M. Holmes, Arti Hurria, Tanya M. Wildes> ;Drugs & Aging. 2018 Mar 27
• 5 citations
  Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature
  Amy Zhou, Amber Afzal, Stephen T. Oh> ;Current Hematologic Malignancy Reports. 2017 Oct 1
• 64 citations
  Mass cytometry analysis reveals hyperactive NF Kappa B signaling in myelofibrosis and secondary acute myeloid leukemia
  Daniel A.C. Fisher, Olga Malkova, Elizabeth K. Engle, Cathrine A. Miner, Mary C. Fulbright, Gregory K. Behbehani, Taylor B. Collins, Shovik Bandyopadhyay, Amy Zhou, Ga...> ;Leukemia. 2017 Sep 1
• 35 citations
  Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia.
  Shovik Bandyopadhyay, Junjie Li, Elie Traer, Jeffrey W. Tyner, Amy Zhou, Stephen T. Oh, Ji-Xin Cheng> ;Plos One. 2017 Jul 18
• 36 citations
  Splanchnic vein thrombosis in myeloproliferative neoplasms: pathophysiology and molecular mechanisms of disease.
  Joan How, Amy Zhou, Stephen T. Oh> ;Therapeutic Advances in Hematology. 2017 Mar 1
• 19 citations
  Clinical Improvement with JAK2 Inhibition in Chuvash Polycythemia.
  Amy Zhou, Eric M. Knoche, Elizabeth K. Engle, Makiko Ban-Hoefen, Charu Kaiwar, Stephen T. Oh> ;The New England Journal of Medicine. 2016 Aug 3
• 10 citations
  Complete Response to Erlotinib and Bevacizumab in a Patient With Biphenotypic (Hepatobiliary) Primary Liver Carcinoma
  Amy Zhou, Manik Amin, Kathryn J. Fowler, Elizabeth M. Brunt, Jesse Keller, Benjamin R. Tan> ;Journal of the National Comprehensive Cancer Network. 2015 Dec 1
• 25 citations
  Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib.
  Amy Zhou, Eric M. Knoche, Elizabeth K. Engle, Daniel A.C. Fisher, Stephen T. Oh> ;Blood Cancer Journal. 2015 Oct 2
• 8 citations
  Outcomes of platelet transfusion in patients with thrombotic thrombocytopenic purpura: a retrospective case series study
  Amy Zhou, Rohtesh S. Mehta, Roy E. Smith> ;Annals of Hematology. 2015 Jan 1
• 22 citations
  End-of-life care planning: improving documentation of advance directives in the outpatient clinic using electronic medical records.
  Salim S. Hayek, Ria Nieva, Frank Corrigan, Amy Zhou, Uma Mudaliar, David Mays, Michael Massoomi, Nurcan Ilksoy> ;Journal of Palliative Medicine. 2014 Dec 15
• 8 citations
  Prognostication in MF: From CBC to cytogenetics to molecular markers
  Amy Zhou, Stephen T. Oh> ;Best Practice & Research. Clinical Haematology. 2014 Jun 1
• 10 citations
  Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?
  Amy Zhou, Anne M. Winkler, Amir Emamifar, Bryce Gartland, Alexander Duncan, Ana G. Antun, Martha Arellano, G. Allen Tindol, Jerrold H. Levy, William A. Bornstein, Ira ...> ;Chest. 2012 Nov 1
• Join now to see all

Abstracts/Posters

• Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of Anemia in Patients with Lower Risk Myelodysplastic Syndrome (LR-MDS) and Low Red Blood Cell (RBC) Transfusion...
  Amy Zhou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Altered Dynamics of Monocyte Subpopulations and Pro-Inflammatory Signaling Pathways in Polycythemia Vera Revealed By Mass Cytometry
  Amy Zhou, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019